Envista Holdings to Present at J.P. Morgan Healthcare Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 14 Jan 26
Source: PRnewswire
Envista Holdings Corp reached a 52-week high, gaining 3.62% in regular trading.
The company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, showcasing its leadership in the dental industry. This event is expected to enhance investor understanding of Envista's strategies and future developments, contributing to its positive stock performance.
This presentation is part of Envista's ongoing efforts to engage with investors and provide insights into its innovative technologies and services, reinforcing its position in the dental market.
Analyst Views on NVST
Wall Street analysts forecast NVST stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVST is 22.22 USD with a low forecast of 18.00 USD and a high forecast of 27.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
5 Buy
7 Hold
1 Sell
Moderate Buy
Current: 24.080
Low
18.00
Averages
22.22
High
27.00
Current: 24.080
Low
18.00
Averages
22.22
High
27.00
About NVST
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
